United States Vasculitis Drug Market Report 2018

February 2018 | 96 pages | ID: UE91E928F8CEN
QYResearch

Abstracts

In this report, the United States Vasculitis Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Vasculitis Drug in these regions, from 2013 to 2025 (forecast).

United States Vasculitis Drug market competition by top manufacturers/players, with Vasculitis Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck
• Bayer
• Farmalider
• Hainan Pharmaceutical Factory
• Shanghaihuangxiang Lantian Pharmaceutical
• Huzhou Konch Pharmaceutical
• CSPC Ouyi Pharmaceutical
• Sino-US Zibo Xinhua-Perrigo Pharmaceutical
• Hubei Biocause Pharmaceutical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Blisibimod
• CCX-168
• Gevokizumab
• Rituximab Biosimilar
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Polyarteritis Nodosa
• Thrombotic Vasculitis
• Granulomatous Vasculitis
• Lymphocytic Vasculitis
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Vasculitis Drug Market Report 2018

1 VASCULITIS DRUG OVERVIEW

1.1 Product Overview and Scope of Vasculitis Drug
1.2 Classification of Vasculitis Drug by Product Category
  1.2.1 United States Vasculitis Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Vasculitis Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Blisibimod
  1.2.4 CCX-168
  1.2.5 Gevokizumab
  1.2.6 Rituximab Biosimilar
  1.2.7 Others
1.3 United States Vasculitis Drug Market by Application/End Users
  1.3.1 United States Vasculitis Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Polyarteritis Nodosa
  1.3.3 Thrombotic Vasculitis
  1.3.4 Granulomatous Vasculitis
  1.3.5 Lymphocytic Vasculitis
  1.3.6 Others
1.4 United States Vasculitis Drug Market by Region
  1.4.1 United States Vasculitis Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Vasculitis Drug Status and Prospect (2013-2025)
  1.4.3 Southwest Vasculitis Drug Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Vasculitis Drug Status and Prospect (2013-2025)
  1.4.5 New England Vasculitis Drug Status and Prospect (2013-2025)
  1.4.6 The South Vasculitis Drug Status and Prospect (2013-2025)
  1.4.7 The Midwest Vasculitis Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Vasculitis Drug (2013-2025)
  1.5.1 United States Vasculitis Drug Sales and Growth Rate (2013-2025)
  1.5.2 United States Vasculitis Drug Revenue and Growth Rate (2013-2025)

2 UNITED STATES VASCULITIS DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Vasculitis Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Vasculitis Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Vasculitis Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States Vasculitis Drug Market Competitive Situation and Trends
  2.4.1 United States Vasculitis Drug Market Concentration Rate
  2.4.2 United States Vasculitis Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Vasculitis Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES VASCULITIS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Vasculitis Drug Sales and Market Share by Region (2013-2018)
3.2 United States Vasculitis Drug Revenue and Market Share by Region (2013-2018)
3.3 United States Vasculitis Drug Price by Region (2013-2018)

4 UNITED STATES VASCULITIS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Vasculitis Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Vasculitis Drug Revenue and Market Share by Type (2013-2018)
4.3 United States Vasculitis Drug Price by Type (2013-2018)
4.4 United States Vasculitis Drug Sales Growth Rate by Type (2013-2018)

5 UNITED STATES VASCULITIS DRUG SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Vasculitis Drug Sales and Market Share by Application (2013-2018)
5.2 United States Vasculitis Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES VASCULITIS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Vasculitis Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck Vasculitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.2 Vasculitis Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Vasculitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Farmalider
  6.3.2 Vasculitis Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Farmalider Vasculitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Hainan Pharmaceutical Factory
  6.4.2 Vasculitis Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Hainan Pharmaceutical Factory Vasculitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Shanghaihuangxiang Lantian Pharmaceutical
  6.5.2 Vasculitis Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Huzhou Konch Pharmaceutical
  6.6.2 Vasculitis Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Huzhou Konch Pharmaceutical Vasculitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 CSPC Ouyi Pharmaceutical
  6.7.2 Vasculitis Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 CSPC Ouyi Pharmaceutical Vasculitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Sino-US Zibo Xinhua-Perrigo Pharmaceutical
  6.8.2 Vasculitis Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Hubei Biocause Pharmaceutical
  6.9.2 Vasculitis Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Hubei Biocause Pharmaceutical Vasculitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview

7 VASCULITIS DRUG MANUFACTURING COST ANALYSIS

7.1 Vasculitis Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Vasculitis Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Vasculitis Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Vasculitis Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES VASCULITIS DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Vasculitis Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Vasculitis Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States Vasculitis Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States Vasculitis Drug Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Vasculitis Drug
Figure United States Vasculitis Drug Market Size (K Pcs) by Type (2013-2025)
Figure United States Vasculitis Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Blisibimod Product Picture
Figure CCX-168 Product Picture
Figure Gevokizumab Product Picture
Figure Rituximab Biosimilar Product Picture
Figure Others Product Picture
Figure United States Vasculitis Drug Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Vasculitis Drug by Application in 2017
Figure Polyarteritis Nodosa Examples
Table Key Downstream Customer in Polyarteritis Nodosa
Figure Thrombotic Vasculitis Examples
Table Key Downstream Customer in Thrombotic Vasculitis
Figure Granulomatous Vasculitis Examples
Table Key Downstream Customer in Granulomatous Vasculitis
Figure Lymphocytic Vasculitis Examples
Table Key Downstream Customer in Lymphocytic Vasculitis
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Vasculitis Drug Market Size (Million USD) by Region (2013-2025)
Figure The West Vasculitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Vasculitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Vasculitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Vasculitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Vasculitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Vasculitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Vasculitis Drug Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Vasculitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Vasculitis Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Vasculitis Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Vasculitis Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Vasculitis Drug Sales Share by Players/Suppliers
Figure 2017 United States Vasculitis Drug Sales Share by Players/Suppliers
Figure United States Vasculitis Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Vasculitis Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Vasculitis Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Vasculitis Drug Revenue Share by Players/Suppliers
Figure 2017 United States Vasculitis Drug Revenue Share by Players/Suppliers
Table United States Market Vasculitis Drug Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Vasculitis Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Vasculitis Drug Market Share of Top 3 Players/Suppliers
Figure United States Vasculitis Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Vasculitis Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Vasculitis Drug Product Category
Table United States Vasculitis Drug Sales (K Pcs) by Region (2013-2018)
Table United States Vasculitis Drug Sales Share by Region (2013-2018)
Figure United States Vasculitis Drug Sales Share by Region (2013-2018)
Figure United States Vasculitis Drug Sales Market Share by Region in 2017
Table United States Vasculitis Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Vasculitis Drug Revenue Share by Region (2013-2018)
Figure United States Vasculitis Drug Revenue Market Share by Region (2013-2018)
Figure United States Vasculitis Drug Revenue Market Share by Region in 2017
Table United States Vasculitis Drug Price (USD/Pcs) by Region (2013-2018)
Table United States Vasculitis Drug Sales (K Pcs) by Type (2013-2018)
Table United States Vasculitis Drug Sales Share by Type (2013-2018)
Figure United States Vasculitis Drug Sales Share by Type (2013-2018)
Figure United States Vasculitis Drug Sales Market Share by Type in 2017
Table United States Vasculitis Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Vasculitis Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Vasculitis Drug by Type (2013-2018)
Figure Revenue Market Share of Vasculitis Drug by Type in 2017
Table United States Vasculitis Drug Price (USD/Pcs) by Types (2013-2018)
Figure United States Vasculitis Drug Sales Growth Rate by Type (2013-2018)
Table United States Vasculitis Drug Sales (K Pcs) by Application (2013-2018)
Table United States Vasculitis Drug Sales Market Share by Application (2013-2018)
Figure United States Vasculitis Drug Sales Market Share by Application (2013-2018)
Figure United States Vasculitis Drug Sales Market Share by Application in 2017
Table United States Vasculitis Drug Sales Growth Rate by Application (2013-2018)
Figure United States Vasculitis Drug Sales Growth Rate by Application (2013-2018)
Table Merck Basic Information List
Table Merck Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck Vasculitis Drug Sales Growth Rate (2013-2018)
Figure Merck Vasculitis Drug Sales Market Share in United States (2013-2018)
Figure Merck Vasculitis Drug Revenue Market Share in United States (2013-2018)
Table Bayer Basic Information List
Table Bayer Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bayer Vasculitis Drug Sales Growth Rate (2013-2018)
Figure Bayer Vasculitis Drug Sales Market Share in United States (2013-2018)
Figure Bayer Vasculitis Drug Revenue Market Share in United States (2013-2018)
Table Farmalider Basic Information List
Table Farmalider Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Farmalider Vasculitis Drug Sales Growth Rate (2013-2018)
Figure Farmalider Vasculitis Drug Sales Market Share in United States (2013-2018)
Figure Farmalider Vasculitis Drug Revenue Market Share in United States (2013-2018)
Table Hainan Pharmaceutical Factory Basic Information List
Table Hainan Pharmaceutical Factory Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Hainan Pharmaceutical Factory Vasculitis Drug Sales Growth Rate (2013-2018)
Figure Hainan Pharmaceutical Factory Vasculitis Drug Sales Market Share in United States (2013-2018)
Figure Hainan Pharmaceutical Factory Vasculitis Drug Revenue Market Share in United States (2013-2018)
Table Shanghaihuangxiang Lantian Pharmaceutical Basic Information List
Table Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales Growth Rate (2013-2018)
Figure Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales Market Share in United States (2013-2018)
Figure Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Revenue Market Share in United States (2013-2018)
Table Huzhou Konch Pharmaceutical Basic Information List
Table Huzhou Konch Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Huzhou Konch Pharmaceutical Vasculitis Drug Sales Growth Rate (2013-2018)
Figure Huzhou Konch Pharmaceutical Vasculitis Drug Sales Market Share in United States (2013-2018)
Figure Huzhou Konch Pharmaceutical Vasculitis Drug Revenue Market Share in United States (2013-2018)
Table CSPC Ouyi Pharmaceutical Basic Information List
Table CSPC Ouyi Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure CSPC Ouyi Pharmaceutical Vasculitis Drug Sales Growth Rate (2013-2018)
Figure CSPC Ouyi Pharmaceutical Vasculitis Drug Sales Market Share in United States (2013-2018)
Figure CSPC Ouyi Pharmaceutical Vasculitis Drug Revenue Market Share in United States (2013-2018)
Table Sino-US Zibo Xinhua-Perrigo Pharmaceutical Basic Information List
Table Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales Growth Rate (2013-2018)
Figure Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales Market Share in United States (2013-2018)
Figure Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Revenue Market Share in United States (2013-2018)
Table Hubei Biocause Pharmaceutical Basic Information List
Table Hubei Biocause Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Hubei Biocause Pharmaceutical Vasculitis Drug Sales Growth Rate (2013-2018)
Figure Hubei Biocause Pharmaceutical Vasculitis Drug Sales Market Share in United States (2013-2018)
Figure Hubei Biocause Pharmaceutical Vasculitis Drug Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Vasculitis Drug
Figure Manufacturing Process Analysis of Vasculitis Drug
Figure Vasculitis Drug Industrial Chain Analysis
Table Raw Materials Sources of Vasculitis Drug Major Players/Suppliers in 2017
Table Major Buyers of Vasculitis Drug
Table Distributors/Traders List
Figure United States Vasculitis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Vasculitis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Vasculitis Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Vasculitis Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Vasculitis Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Vasculitis Drug Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Vasculitis Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Vasculitis Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Vasculitis Drug Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Vasculitis Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Vasculitis Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Vasculitis Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Vasculitis Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources